Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD episode artwork

EPISODE · Nov 12, 2025 · 37 MIN

Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD

from Speaking of Psychology · host American Psychological Association

Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U.S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how weight loss can shift people's relationships with their family, friends and partners; and why there’s still stigma around the use of GLP-1s and how patients can navigate that. Find Dr. Rachel's new book at When Life Happens: The Mindset Shift You Need to Manage Stress, Build Confidence, and Break Free. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Nov 12, 2025

Embed this episode

NOW PLAYING

Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD

0:00 37:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Speaking of Psychology?

This episode is 37 minutes long.

When was this Speaking of Psychology episode published?

This episode was published on November 12, 2025.

Can I download this Speaking of Psychology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!